The leader of the clinical study of the COVID-19 vaccine from AstraZeneca plc (Nasdaq: AZN) at the Indiana University School of Medicine says there has been no evidence of any blood clot-related side... Read More
Indianapolis-based Eli Lilly and Co. is touting the results of a Phase 2 clinical trial involving one of its COVID-19 antibody therapies. Lilly says the trial, conducted along with California-based Vi... Read More
Indiana's life sciences industry continued to grow in 2020 despite the pandemic, according to new data from the Indiana Business Research center at the IU Kelley School of Business. BioCrossroads says... Read More
An Ohio-based radiopharmaceutical contract manufacturer is growing its operations in Indianapolis. Cardinal Health has announced plans for a multi-million-dollar expansion that will include the additi... Read More
West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) is growing its services. The contract research services company plans to expand its offerings by adding cardiovascular safety pharmacolog... Read More
Indianapolis-based Eli Lilly and Co. says the combination of two of its COVID-19 antibody therapies continues to reduce hospitalizations and death in high-risk patients recently diagnosed with the dis... Read More
A New York-based pharmacy automation solutions company has announced plans to open its new global headquarters in Indianapolis. iA, which has created a software-enabled pharmacy fulfillment platform,... Read More
More COVID-19 vaccine doses will soon be made available to Americans, and they will come from a production facility in Bloomington. New Jersey-based Catalent Inc. (NYSE: CTLT) has been manufacturing t... Read More
A Cleveland-based technology firm is setting up shop in the Discovery Park District at Purdue University. IdentifySensors Biologics is partnering with the Purdue Research Foundation to grow its effort... Read More
Indianapolis-based Eli Lilly and Co. is reporting positive results from two Phase 3 clinical trials of a drug designed to help people with type 2 diabetes. Lilly says tirzepatide led to "significant A... Read More
A Warsaw-based medical device startup has closed on a $400,000 seed round of funding. Eclipse Orthopaedics says it will use the funding, along with previous grant awards, to accelerate product develop... Read More
While much of the country and the state of Indiana are struggling to manage the pandemic, local life sciences leaders point to the state’s research universities for creating the playbook for how to mo... Read More
A new study is underway—with mostly Boilermakers enrolled—to see if smartwatches could provide the earliest clues that the wearer could be developing COVID-19, even before the first hint of a symptom.... Read More
Boosted by a recent dose of funding, Carmel-based Confluence Pharmaceuticals is taking aim at Phase 2 clinical trials for its drug, which company leaders believe will restore hope and unlock potential... Read More
Chest pain is the second most common reason people rush to the emergency room (ER), but only one in five patients is actually having a cardiac event. The vast majority of people with chest pain are se... Read More
Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has selected Vafa Jamali as chief executive officer of NewCo, the spine and dental businesses of Zimmer Biomet that will spin off into an independe... Read More
New Jersey-based J. Knipper and Company Inc. says it plans to invest $17.4 million to expand its distribution center located in the River Ridge Commerce Center and grow its workforce by 38 people. Kni... Read More
Indianapolis-based Apria Inc. (Nasdaq: APR) has begun listing on the Nasdaq Global Select Market after an Initial Public Offering this week. The home healthcare equipment provider is looking to raise... Read More
West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) is reporting a fiscal first quarter net loss of $366,000, compared to a loss of $1.4 million during the same period the previous year. Ch... Read More
The U.S. Food and Drug Administration has granted an Emergency Use Authorization for two COVID-19 antibody therapies from Indianapolis-based Eli Lilly and Co. (NYSE: LLY). The company says the combina... Read More
